HEADER OXIDOREDUCTASE 17-MAR-08 3CKU TITLE URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH ITS INHIBITOR 8- TITLE 2 AZAXANTHIN AND CHLORIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: URICASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: URATE OXIDASE; COMPND 5 EC: 1.7.3.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ASPERGILLUS FLAVUS; SOURCE 3 ORGANISM_TAXID: 5059; SOURCE 4 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS OXIDOREDUCTASE, URIC ACID DEGRADATION, 8-AZAXHANTIN EXPDTA X-RAY DIFFRACTION AUTHOR N.COLLOC'H,T.PRANGE REVDAT 3 01-NOV-23 3CKU 1 REMARK LINK REVDAT 2 24-FEB-09 3CKU 1 VERSN REVDAT 1 07-OCT-08 3CKU 0 JRNL AUTH N.COLLOC'H,L.GABISON,G.MONARD,M.ALTARSHA,M.CHIADMI, JRNL AUTH 2 G.MARASSIO,J.SOPKOVA-DE OLIVEIRA SANTOS,M.EL HAJJI,B.CASTRO, JRNL AUTH 3 J.H.ABRAINI,T.PRANGE JRNL TITL OXYGEN PRESSURIZED X-RAY CRYSTALLOGRAPHY: PROBING THE JRNL TITL 2 DIOXYGEN BINDING SITE IN COFACTORLESS URATE OXIDASE AND JRNL TITL 3 IMPLICATIONS FOR ITS CATALYTIC MECHANISM. JRNL REF BIOPHYS.J. V. 95 2415 2008 JRNL REFN ISSN 0006-3495 JRNL PMID 18375516 JRNL DOI 10.1529/BIOPHYSJ.107.122184 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.COLLOC'H,M.EL HAJJI,B.BACHET,G.L'HERMITE,M.SCHILTZ, REMARK 1 AUTH 2 T.PRANGE,B.CASTRO,J.P.MORNON REMARK 1 TITL CRYSTAL STRUCTURE OF THE PROTEIN DRUG URATE REMARK 1 TITL 2 OXIDASE-INHIBITOR COMPLEX AT 2.05 A RESOLUTION. REMARK 1 REF NAT.STRUCT.BIOL. V. 4 947 1997 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 9360612 REMARK 1 DOI 10.1038/NSB1197-947 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.RETAILLEAU,N.COLLOC'H,D.VIVARES,F.BONNETE,B.CASTRO, REMARK 1 AUTH 2 M.EL-HAJJI,J.P.MORNON,G.MONARD,T.PRANGE REMARK 1 TITL COMPLEXED AND LIGAND-FREE HIGH-RESOLUTION STRUCTURES OF REMARK 1 TITL 2 URATE OXIDASE (UOX) FROM ASPERGILLUS FLAVUS: A REASSIGNMENT REMARK 1 TITL 3 OF THE ACTIVE-SITE BINDING MODE. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 60 453 2004 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 14993669 REMARK 1 DOI 10.1107/S0907444903029718 REMARK 1 REFERENCE 3 REMARK 1 AUTH N.COLLOC'H,J.SOPKOVA-DE OLIVEIRA SANTOS,P.RETAILLEAU, REMARK 1 AUTH 2 D.VIVARES,F.BONNETE,B.LANGLOIS D'ESTAINTO,B.GALLOIS, REMARK 1 AUTH 3 A.BRISSON,J.J.RISSO,M.LEMAIRE,T.PRANGE,J.H.ABRAINI REMARK 1 TITL PROTEIN CRYSTALLOGRAPHY UNDER XENON AND NITROUS OXIDE REMARK 1 TITL 2 PRESSURE: COMPARISON WITH IN VIVO PHARMACOLOGY STUDIES AND REMARK 1 TITL 3 IMPLICATIONS FOR THE MECHANISM OF INHALED ANESTHETIC ACTION. REMARK 1 REF BIOPHYS.J. V. 92 217 2007 REMARK 1 REFN ISSN 0006-3495 REMARK 1 PMID 17028130 REMARK 1 DOI 10.1529/BIOPHYSJ.106.093807 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.200 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.197 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3340 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 43014 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.198 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.183 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3230 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 42048 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2362 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 13 REMARK 3 SOLVENT ATOMS : 275 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2651.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 10 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 10759 REMARK 3 NUMBER OF RESTRAINTS : 9913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.033 REMARK 3 ANGLE DISTANCES (A) : 0.077 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.042 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.058 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.013 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.061 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CKU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000046898. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.964 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : BENT MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42048 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05550 REMARK 200 R SYM (I) : 0.05310 REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.09900 REMARK 200 R SYM FOR SHELL (I) : 0.08400 REMARK 200 FOR SHELL : 13.70 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: FFT REMARK 200 STARTING MODEL: 1R4S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2MG/ML 8-AZAXANTHIN, 0.3M SODIUM REMARK 280 CHLORIDE, 0.05M TRIS/HCL, 10-15% W/V PEG 8000, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291K, PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.49700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.48950 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 52.19050 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.49700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.48950 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 52.19050 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.49700 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.48950 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 52.19050 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.49700 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.48950 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 52.19050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 26430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 42840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -212.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 78.99400 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 94.97900 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 78.99400 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 104.38100 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 94.97900 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 104.38100 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 296 REMARK 465 LEU A 297 REMARK 465 LYS A 298 REMARK 465 SER A 299 REMARK 465 LYS A 300 REMARK 465 LEU A 301 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ACE A 0 C SER A 1 N 0.236 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ACE A 0 O - C - N ANGL. DEV. = 12.2 DEGREES REMARK 500 SER A 1 C - N - CA ANGL. DEV. = -21.7 DEGREES REMARK 500 TYR A 65 CB - CG - CD2 ANGL. DEV. = -6.8 DEGREES REMARK 500 ARG A 176 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 118 26.22 -153.92 REMARK 500 SER A 124 148.98 166.76 REMARK 500 ASP A 175 104.37 -163.50 REMARK 500 SER A 226 168.26 175.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 303 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ILE A 88 O REMARK 620 2 TYR A 91 O 81.8 REMARK 620 3 ASN A 92 O 148.9 74.6 REMARK 620 4 ILE A 94 O 102.6 86.4 95.8 REMARK 620 5 GLU A 136 OE1 106.7 167.1 100.3 82.3 REMARK 620 6 HOH A 524 O 85.6 105.2 81.5 166.8 85.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZA A 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R51 RELATED DB: PDB REMARK 900 URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH ITS INHIBITOR REMARK 900 8-AZAXANTHIN REMARK 900 RELATED ID: 2IBA RELATED DB: PDB REMARK 900 URATE OXIDASE FROM ASPERGILLUS FLAVUS COMPLEXED WITH ITS INHIBITOR REMARK 900 8-AZAXANTHINE REMARK 900 RELATED ID: 2IC0 RELATED DB: PDB REMARK 900 URATE OXIDASE UNDER 2.0 MPA PRESSURE OF XENON DBREF 3CKU A 1 301 UNP Q00511 URIC_ASPFL 2 302 SEQRES 1 A 302 ACE SER ALA VAL LYS ALA ALA ARG TYR GLY LYS ASP ASN SEQRES 2 A 302 VAL ARG VAL TYR LYS VAL HIS LYS ASP GLU LYS THR GLY SEQRES 3 A 302 VAL GLN THR VAL TYR GLU MET THR VAL CYS VAL LEU LEU SEQRES 4 A 302 GLU GLY GLU ILE GLU THR SER TYR THR LYS ALA ASP ASN SEQRES 5 A 302 SER VAL ILE VAL ALA THR ASP SER ILE LYS ASN THR ILE SEQRES 6 A 302 TYR ILE THR ALA LYS GLN ASN PRO VAL THR PRO PRO GLU SEQRES 7 A 302 LEU PHE GLY SER ILE LEU GLY THR HIS PHE ILE GLU LYS SEQRES 8 A 302 TYR ASN HIS ILE HIS ALA ALA HIS VAL ASN ILE VAL CYS SEQRES 9 A 302 HIS ARG TRP THR ARG MET ASP ILE ASP GLY LYS PRO HIS SEQRES 10 A 302 PRO HIS SER PHE ILE ARG ASP SER GLU GLU LYS ARG ASN SEQRES 11 A 302 VAL GLN VAL ASP VAL VAL GLU GLY LYS GLY ILE ASP ILE SEQRES 12 A 302 LYS SER SER LEU SER GLY LEU THR VAL LEU LYS SER THR SEQRES 13 A 302 ASN SER GLN PHE TRP GLY PHE LEU ARG ASP GLU TYR THR SEQRES 14 A 302 THR LEU LYS GLU THR TRP ASP ARG ILE LEU SER THR ASP SEQRES 15 A 302 VAL ASP ALA THR TRP GLN TRP LYS ASN PHE SER GLY LEU SEQRES 16 A 302 GLN GLU VAL ARG SER HIS VAL PRO LYS PHE ASP ALA THR SEQRES 17 A 302 TRP ALA THR ALA ARG GLU VAL THR LEU LYS THR PHE ALA SEQRES 18 A 302 GLU ASP ASN SER ALA SER VAL GLN ALA THR MET TYR LYS SEQRES 19 A 302 MET ALA GLU GLN ILE LEU ALA ARG GLN GLN LEU ILE GLU SEQRES 20 A 302 THR VAL GLU TYR SER LEU PRO ASN LYS HIS TYR PHE GLU SEQRES 21 A 302 ILE ASP LEU SER TRP HIS LYS GLY LEU GLN ASN THR GLY SEQRES 22 A 302 LYS ASN ALA GLU VAL PHE ALA PRO GLN SER ASP PRO ASN SEQRES 23 A 302 GLY LEU ILE LYS CYS THR VAL GLY ARG SER SER LEU LYS SEQRES 24 A 302 SER LYS LEU HET ACE A 0 3 HET CL A 304 1 HET NA A 303 1 HET AZA A 302 11 HETNAM ACE ACETYL GROUP HETNAM CL CHLORIDE ION HETNAM NA SODIUM ION HETNAM AZA 8-AZAXANTHINE FORMUL 1 ACE C2 H4 O FORMUL 2 CL CL 1- FORMUL 3 NA NA 1+ FORMUL 4 AZA C4 H3 N5 O2 FORMUL 5 HOH *275(H2 O) HELIX 1 1 ILE A 42 LYS A 48 1 7 HELIX 2 2 ASP A 50 ILE A 54 5 5 HELIX 3 3 ALA A 56 ASN A 71 1 16 HELIX 4 4 PRO A 75 TYR A 91 1 17 HELIX 5 5 GLY A 193 HIS A 200 1 8 HELIX 6 6 HIS A 200 ASP A 222 1 23 HELIX 7 7 SER A 226 GLN A 242 1 17 HELIX 8 8 THR A 271 ALA A 275 5 5 SHEET 1 A 8 TYR A 8 LYS A 20 0 SHEET 2 A 8 GLN A 27 GLY A 40 -1 O LEU A 38 N TYR A 8 SHEET 3 A 8 ILE A 94 HIS A 104 -1 O HIS A 98 N LEU A 37 SHEET 4 A 8 LYS A 127 VAL A 135 -1 O VAL A 132 N VAL A 99 SHEET 5 A 8 ILE A 140 LYS A 153 -1 O ASP A 141 N ASP A 133 SHEET 6 A 8 LEU A 178 TRP A 188 -1 O VAL A 182 N LEU A 149 SHEET 7 A 8 ILE A 245 ASN A 254 -1 O GLU A 249 N THR A 185 SHEET 8 A 8 GLY A 286 VAL A 292 -1 O ILE A 288 N LEU A 252 SHEET 1 B 2 THR A 107 ILE A 111 0 SHEET 2 B 2 LYS A 114 ILE A 121 -1 O HIS A 116 N MET A 109 SHEET 1 C 2 TYR A 257 GLU A 259 0 SHEET 2 C 2 PHE A 278 PRO A 280 -1 O ALA A 279 N PHE A 258 LINK C ACE A 0 N SER A 1 1555 1555 1.57 LINK O ILE A 88 NA NA A 303 1555 1555 2.35 LINK O TYR A 91 NA NA A 303 1555 1555 2.56 LINK O ASN A 92 NA NA A 303 1555 1555 2.64 LINK O ILE A 94 NA NA A 303 1555 1555 2.36 LINK OE1 GLU A 136 NA NA A 303 1555 1555 2.47 LINK NA NA A 303 O HOH A 524 1555 1555 2.36 CISPEP 1 THR A 74 PRO A 75 0 -8.61 CISPEP 2 ASP A 283 PRO A 284 0 -10.69 SITE 1 AC1 4 THR A 57 ASN A 254 HIS A 256 GLY A 286 SITE 1 AC2 6 ILE A 88 TYR A 91 ASN A 92 ILE A 94 SITE 2 AC2 6 GLU A 136 HOH A 524 SITE 1 AC4 9 ILE A 54 ALA A 56 THR A 57 PHE A 159 SITE 2 AC4 9 ARG A 176 SER A 226 GLN A 228 ASN A 254 SITE 3 AC4 9 HOH A 401 CRYST1 78.994 94.979 104.381 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012659 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010529 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009580 0.00000 HETATM 1 C ACE A 0 60.920 57.560 19.610 1.00 32.61 C HETATM 2 O ACE A 0 60.410 56.630 19.090 1.00 57.13 O HETATM 3 CH3 ACE A 0 62.390 57.940 19.400 1.00 54.45 C